https://tyra.bio/tyra-biosciences-raises-50m-to-develop-therapies-targeting-acquired-resistance-in-oncology/2021-08-02T13:05:37-07:00https://tyra.bio/tyra-biosciences-raises-106m-in-series-b-financing-to-advance-novel-pipeline-of-therapies-targeting-acquired-resistance-in-oncology/2021-08-02T21:37:05-07:00